A bloodstream infection (BSI) is defined as one or more positive blood cultures associated with systemic signs of infection such as fevers, chills, and/or hypotension. BSIs can be divided into primary and secondary. Primary BSIs occur without another defined nidus of infection. Secondary BSIs develop from a detectable area of infection as the source of the bacteremia. An example of such a secondary BSI is a urinary tract infection with subsequent bacteremia.
- BSI often are iatrogenic owing to invasive procedures or devices such as the placement of a central venous catheter.
- Vascular catheter-related BSIs are the most common cause of healthcare-associated bacteremia.
- In contrast, peripheral venous catheters less commonly cause BSI.
- Prevention of catheter-related BSIs is a high priority infection prevention initiative
- An estimated 250,000 cases of BSIs occur annually in the U.S.
- 80,000 of these are catheter-related BSIs that occur in ICUs.
- BSIs greatly increase hospital cost and length of stay.
- The estimated BSI attributable mortality rate is between 12-25%.
- Catheter-related bloodstream infections account for 11% of healthcare-associated infections.
- Most frequently isolated BSI organisms include coagulase-negative staphylococci (31%), Staphylococcus aureus— either methicillin sensitive or resistant (20%), enterococci (9%), Escherichia coli(6%), Klebsiellaspecies (5%), and Candidaspecies (9%).
- Independent risk factors for central line associated BSIs include:
- Prolonged hospitalization before catheterization.
- Prolonged duration of catheterization.
- Heavy microbial colonization at the insertion site and/or catheter hub.
- Femoral catheterization in adults.
- Reduced nurse-to-patient ratio in the ICU.
- Total parenteral nutrition.
- Implementation of proven infection reduction techniques is associated with 60% decrease in catheter-related BSI rates in U.S. intensive care units.
- Education and training of healthcare workers.
- Hospital infection control policies with surveillance for intravascular device-related infection
- The placement and use of central line involves five key components:
- Appropriate hand hygiene involving the use of alcohol-based waterless hand cleaner or antibacterial soap and water with adequate rinsing.
- Use of maximal barrier precautions: strict adherence to hand hygiene; wearing surgical cap, mask, sterile gown, and sterile gloves; and use of sterile drapes.
- Skin preparation with 2% chlorhexidine in 70% isopropyl alcohol.
- Use of an optimal catheter site such as the subclavian area and avoidance of a femoral site.
- Ongoing daily reviews of central line necessity with removal as soon as possible.
- Disinfect injection ports prior to use and stopcocks should be capped when not in use.
- Use Teflon or polyurethane catheters instead of polyvinyl chloride or polyethylene catheters.
- Change sterile gauze dressings every 2 days with transparent dressing changes every 7 days.
- Placing chlorhexidine-impregnated sponges (Biopatch) at catheter sites is associated with significant reduction in BSI rates.
- Daily skin cleansing with 2% chlorhexidine wash reduces BSI rates.
- Using antimicrobial-coated catheters should be considered if duration of device use is longer than 5 days.
- Replace tubing used for blood products, lipid emulsions, and propofol infusions.
- Use sutureless securement devices.
- Use peripheral catheters as opposed to central venous catheters whenever possible, although peripheral catheters can also be associated with BSI.
- Tunneled central venous catheters should be preferentially employed for long term use (>7 days of catheterization).
PRACTICES CURRENTLY NOT RECOMMENDED
- Do not use topical antimicrobials at insertions sites except when with dialysis catheters
- Do not use in-line filters for infection prevention.
- Do not use antibacterial lock solutions routinely. Antimicrobial locks should only be used under special circumstances such as patients with history of multiple catheter related bloodstream infections despite adequate precautions
- Do not use guidewire catheter exchanges to change out suspected infected catheters.
- Do not routinely use anticoagulant therapy to reduce catheter-related infection risk.
SUGGESTED PRACTICE IN UNDER-RESOURCED SETTINGS
The hand-washing catheter insertion and care bundles outlined above can be used in under-resourced settings and have been shown to decrease catheter-associated bloodstream infections in South America and Asia as well as they have in the United States and Western Europe. These interventions not only are successful in regard to decreasing the number of bloodstream infections but are associated with substantial savings to the hospital.
The most common cause of healthcare-associated bacteremia is catheter-related bloodstream infection. These infections increase morbidity, mortality, length of stay, and hospital costs. Implementing the practices above has been shown to decrease these rates and improve quality of care for our patients.
- Álvarez-Moreno CA, Valderrama-Beltrán SL, Rosenthal VD,, et al. Multicenter Study in Colombia: Impact of a Multidimensional International Nosocomial Infection Control Consortium (INICC) Approach on Central Line-Associated Bloodstream Infection Rates. Am J Infect Control. 2016; 44(11):e235–e241. doi: 10.1016/j.ajic.2016.03.043.
- Arvaniti K, Lathyris D, Blot S, et al. Cumulative Evidence of Randomized Controlled and Observational Studies on Catheter-Related Infection Risk of Central Venous Catheter Insertion Site in ICU Patients: a Pairwise and Network Meta-Analysis. Crit Care Med. 2017; 45: e437–e448.
- Fagan RP, Edwards JR, Park BJ, et al. Incidence Trends in Pathogen-Specific Central Line–Associated Bloodstream Infections in Us Intensive Care Units, 1990-2010. Infect Cont Hosp Epidemiol. 2013; 34(9):893–9.
- Janum S, Zingg W, Classen V, Afshari A. Bench-To-Bedside Review: Challenges of Diagnosis, Care and Prevention of Central Catheter-Related Bloodstream Infections in Children. Crit Care. 2013; 17(4): 238. doi: 10.1186/cc12730.
- Lin WP, Chang YC, Wu UI, et al. Multimodal Interventions for Bundle Implementation to Decrease Central Line-Associated Bloodstream Infections in Adult Intensive Care Units in a Teaching Hospital in Taiwan, 2009-2013. J Microbiol Immunol Infect. 2017. pii: S1684–1182(17)30189-5. doi: 10.1016/j.jmii.2017.08.008.
- Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014; 35(7):753–71. doi: 10.1086/676533.
- Mermel LA. Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: a Systematic Review. Clin Infect Dis. 2017; 65(10): 1757–62. doi: 10.1093/cid/cix562.
- Nuckols TK, Keeler E, Morton SC, et al. Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: a Systematic Review. JAMA Intern Med. 2016; 176(12):1843–54. doi: 10.1001/jamainternmed.2016.6610.
- O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections. Am J Infect Control. 2011; 39(4 Suppl 1):S1–34. doi: 10.1016/j.ajic.2011.01.003.
- Padilla Fortunatti CF. Impact of Two Bundles on Central Catheter-Related Bloodstream Infection in Critically Ill Patients. Rev Lat Am Enfermagem. 2017; 25:e2951. doi: 10.1590/1518-8345.2190.2951.
- Pronovost P, Needham D, Berenholtz S, et al. An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med. 2006; 355(26):2725–32.
- Timsit J-F; Schwebel C; Bouadma L, et al. Chlorhexidine-Impregnated Sponges and Less Frequent Dressing Changes for Prevention of Catheter-Related Infections in Critically Ill Adults: a Randomized Controlled Trial. JAMA. 2009; 301(12):1231–1. doi: 10.1001/jama.2009.376.
- Van der Kooi T, Sax H, Pittet D, et al. Prevention of Hospital Infections by Intervention and Training (Prohibit): Results of a Pan-European Cluster-Randomized Mutlicentre Study to Reduce Central Venous Catheter-Related Infections. Intensive Care Med. 2018; 44(1):48–60. doi: 10.1007/s00134-017-5007-6.